Home › Urothelial (Transitional Cell) Carcinoma › Wisconsin › Milwaukee
Urothelial (Transitional Cell) Carcinoma clinical trials in Milwaukee, WI
6 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in and around Milwaukee (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecruitingPhase 1
- Exelixis Clinical Site #33, Milwaukee
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- and 7 more
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RecruitingPhase 1
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RecruitingPhase 2
- Froedtert Hospital/Medical College of Wisconsin, Milwaukee
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
RecruitingPhase 3
- Research Site, Milwaukee
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Milwaukee
Urothelial (Transitional Cell) Carcinoma trials in other cities
- Nashville, TN23 studies
- New York City, NY22 studies
- Houston, TX19 studies
- Dallas, TX18 studies
- Edison, NJ18 studies
- Los Angeles, CA17 studies
- Queens, NY15 studies
- Chicago, IL14 studies
- Arlington, VA12 studies
- Boston, MA11 studies
- San Antonio, TX11 studies
- Austin, TX10 studies
Other studies in Milwaukee
- Breast Cancer23 studies
- Cancer (all types)22 studies
- Non-Small Cell Lung Cancer22 studies
- Multiple Myeloma21 studies
- Lung Cancer21 studies
- Prostate Cancer20 studies
- Follicular Lymphoma19 studies
- Non-Hodgkin Lymphoma18 studies
- Pancreatic Cancer18 studies
- Acute Myeloid Leukemia17 studies
- Ovarian Cancer17 studies
- Diffuse Large B-Cell Lymphoma16 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.